Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05551455
Other study ID # 22/SPS/026
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 4, 2022
Est. completion date December 9, 2022

Study information

Verified date October 2023
Source Liverpool John Moores University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Using a randomised crossover design, nine weight-stable men, aged 18 - 40 years old, will be recruited via convenience sampling from the staff and student body of LJMU and local area. Participants will be asked to follow two 4-day (~96 hours) periods of tightly controlled exercise energy expenditure (15 kcal/kg FFM/day [cycling]) and dietary intake (60 kcal/kg FFM/day) to compare a state of 'normal' energy availability (or energy balance; equivalent to 45 kcal/kg FFM/day) with concomitant 1: normal carbohydrate availability ('Normal'; ~60% of dietary intake from carbohydrate) and 2: low carbohydrate availability ('LCHF', ~1.5 g/kg carbohydrate per day, ~70 - 80% dietary intake from fat). This approximates the amount of carbohydrate consumed by an individual in a state of LEA through consuming 10 kcal/kg FFM/day with 50% of intake from carbohydrate, or ~1.5 g/kg/day of carbohydrate. In both experimental phases we will measure endocrine, metabolic and physiological parameters.


Description:

Rationale: The primary research question associated with this study is 'What is the impact of an acute period of low carbohydrate availability upon associated physiological and endocrinological markers in a cohort of healthy males?' Extensive research has been conducted since the 1970s to determine the aetiology behind the concurrent impairment of reproductive function and low bone mineral density that is commonly observed in exercising females (De Souza et al., 2014). This research has determined that chronic low energy availability ('LEA' - the energy available from diet after energy used in exercise has been subtracted) is the key determining factor for the endocrine and physiological responses observed in the Female Athlete Triad (De Souza et al., 2014) model. However, whilst the Male Athlete Triad (Nattiv et al., 2021) and RED-S (Mountjoy et al., 2018) models identify the likely impact of LEA upon males, equivalent research identifying the physiological effects of this state in males is far behind that of females. Moreover, whilst low energy availability has been identified as the key driver of the physiological dysregulations identified in the Female/Male Athlete Triad and RED-S models, much of the existing research has not adequately delineated between the impact of low energy availability, per se, and low carbohydrate availability. Recent research suggests that low carbohydrate availability, with or without the presence of LEA, may be a driver of the physiological dysregulations identified within the aforementioned models. For example, McKay et al (2021) have shown altered iron and immune responses and impaired exercise performance following 6-days of low carbohydrate (50 - 100 g/day) but ~normal energy availability (40 kcal•kg FFM-1•day-1), whilst no changes were apparent in a LEA (15 kcal•kg FFM-1•day-1, 60% carbohydrate) and a control group. Similarly, Heikura et al (2020) have recently shown that over 3.5 weeks, a ketogenic diet impairs markers of bone turnover compared to an energy-matched high carbohydrate diet in highly trained athletes. Given that exercise and nutritional interventions are key for improving weight-loss and health of the general population, understanding how reduced energy and/or carbohydrate availability may affect male endocrinology and physiology is of the utmost importance. The effects and mechanisms by which low energy and/or carbohydate availability influences male physiological function therefore requires further research using well-controlled experimental research designs. We have recently conducted a study that aimed to understand the broad physiological, endocrine and muscular responses to a period of five-days of low energy availability (analysis of samples is ongoing). The proposed study therefore now aims to extend the scope of our research to investigate the impact of four- days of low carbohydrate availability using a low-carbohydrate, high-fat diet in the presence of adequate energy availability to address this gap in the literature. Objectives: Primary: To investigate the physiological responses of adult males to low carbohydrate availability whilst in energy balance over 4-days (~96 hrs, spanning five testing mornings), in contrast to an equivalent period of controlled energy balance with 'normal' carbohydrate availability in relation to muscle and endocrine parameters. Secondary: To investigate the wider physiological responses of adult males to low carbohydrate availability (whilst in energy balance) over 4-days (~96 hrs, spanning five testing mornings), compared to an equivalent period in controlled 'normal' carbohydrate availability in relation to whole-body physiological and metabolic status as well as body composition changes. Study Methods: Using a randomised cross-over design, participants will complete two interventions that will elicit conditions of 'normal' (NEA) and 'low' (LEA) carbohydrate availability whilst in energy balance, with a 10-day washout period in between conditions. Body composition changes and markers of bone turnover and reproductive health will be assessed, along with further physiological parameters. Sample Size: Sample size was determined based upon the primary outcome measure of Free Circulating Testosterone, the least sensitive primary outcome measures of the study. The findings of Koehler et al (2016) were used to estimate required sample size for this study. Koehler et al (2016) reported a non-significant (P >0.05) change in Testosterone following four days of Low Energy Availability (with exercise) at 15 kcal/kg FFM/day (LEA + Ex: Pre 5.27 ± 0.46, Post 4.46 ± 0.96 ng.ml-1), compared to a control group with exercise (C + Ex: Pre 4.98 ± 0.47 Post 4.92 ± 0.53 ng.ml-1). However, a large effect size for the reduction in testosterone concentrations for LEA + Ex compared to C + Ex (d = 1.36) was observed/calculated. Therefore a post-hoc power analysis was conducted, revealing a power (1-β err probability) of 0.759 for the sample size of N = 6. To replicate these findings with greater statistical power (α err prob 0.05, 1-β err prob > 0.9) would require 8 participants, with 9 participants required to factor for a potential 10% dropout rate in participants commonly observed. Quality: The research plan has been reviewed internally within the research team at Liverpool John Moores University. The researcher's associated with this study and associated with the review of the study protocol are all members of staff (or a PhD Student) within the Liverpool John Moores University Research Institute for Sport & Exercise Sciences (RISES). In the 2014 RISES (LJMU) submitted 34.75 FTE (full time equivalent) to Unit of Assessment 26 (UoA26) and attained a GPA (Grade Point Average) of 3.57. Placed second on GPA in the UoA, RISES became the leading centre for Sport and Exercise Science Research Quality in the UK (4* - 61% of all activity world leading, 3* - 36% of all activity internationally excellent standard). RISES submitted the largest volume of 4* outputs (n=60) in the UoA, had 90% of the impact activity rated at 4* and had 100% of the environment rated as 4*. Importantly, out of 1,911 submissions in all 36 UoA's RISES came 11th in the entire UK for GPA achieved at REF2014, putting RISES (LJMU) amongst Oxford, UCL, LSE and Cambridge in the league tables for this metric. This makes RISES perfectly qualified to assess this research project.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date December 9, 2022
Est. primary completion date December 9, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Gender/Sex: Male - Age:18-40 - Healthy (as determined by pre-participation questionnaires) - Regularly Exercising/Aerobically trained (3 + times/week, VO2max >50 ml/kg/min), as determined through participant self-identification via recruitment email/verbal communication and baseline assessment of VO2max) - Weight-stable (within 2 kg) for the past 6-months Exclusion Criteria: - Gender/Sex: Female/Other - Age - < 18 - > 40 - Health - Deemed unable to perform exercise (assessed via PAR-Q) - Current smoker. - Medical Condition - Those with any previous diagnosis of; Osteoporosis/low bone mineral density, cardio-vascular disease, Diabetes Mellitus, Cerebrovascular Disease, blood-related illness/disorder, Asthma or other respiratory illness/disorder, Liver Disease, Kidney Disease, gastrointestinal disease, Eating Disorder or Disordered Eating. Those currently taking prescription medication or unwell with a cold or virus at the time of participation. - Those unwilling to adhere to the study's methodological requirements (including adhering to alterations in diet and training - inc. alcohol abstention) from the day prior to intervention onset (24 hrs pre-intervention) to completion of follow-up assessments (day 5). - Those following a restrictive diet (e.g. vegans) - Those with food allergies and/or food intolerances - Training status - Does not train 3 + times/week (over past 6 months on average) and/or have a VO2max >50 ml/kg/min. - Any athletes that may be tested for substances on the WADA banned substances list

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Nutritional/dietary intake manipulation ('Normal')
Energy Intake provision (60 kcal/kg FFM/day) to elicit 'normal' energy availability (45 kcal/kg FFM/day), with 60% from carbohydrates.
Nutritional/dietary intake manipulation ('Low')
Energy Intake provision (60 kcal/kg FFM/day), with 1.5 g/kg of carbohydrate and 70-80% fat intake, to elicit 'low' carbohydrate availability in energy balance (45 kcal/kg FFM/day).

Locations

Country Name City State
United Kingdom Liverpool John Moores University Liverpool Merseyside

Sponsors (1)

Lead Sponsor Collaborator
Liverpool John Moores University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in blood bone turnover markers: ß-CTX (Bone Resorption) Analysis of changes in blood-borne bone (re)modelling marker ß-CTX (Bone Resorption) following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Primary Changes in blood bone turnover markers: P1NP (Bone Formation) Analysis of changes in blood-borne bone (re)modelling marker P1NP (Bone Formation) Days 1, 2, 3, 4 & 5 per intervention
Primary Changes in blood metabolites/hormones: Testosterone Analysis of changes to circulating testosterone concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Change in resting substrate utilisation Analysis of changes in resting substrate utilisation. Assessed using indirect calorimetry. Days 1, 3 and 5 of each intervention
Secondary Changes in sub-maximal Exercise Energy Expenditure Analysis of changes in sub-max exercise energy expenditure and substrate utilisation at standardised exercise intensities. Assessed using indirect calorimetry. Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in sub-maximal exercise substrate utilisation Analysis of changes in sub-max exercise energy expenditure and substrate utilisation at standardised exercise intensities. Assessed using indirect calorimetry. Days 1, 2, 3, 4 & 5 per intervention
Secondary Immune function Analysis of changes to saliva-based markers of immune function Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Initial Orthostatic Hypotension (IOH) Analysis of changes in IOH, assessed via blood pressure finometry and questionnaire Pre- and post-intervention (days 1 and 5) for both intervention
Secondary Change in Profile of Mood States Analysis of changes in Psychological/mood, assessed via the POMS-40 questionnaire Pre- and post-intervention (days 1 and 5) per intervention
Secondary Change in subjective hunger Analsis of changes in subjective hunger, assessed via visual analogue scales Days 1, 2, 3, 4 & 5 per intervention
Secondary Change in sexual drive/libido Analysis of subjective sex-drive/libido changes, assessed via visual analogue scale Pre- and post-intervention (days 1 and 5)
Secondary Physical activity energy expenditure (PAEE) Analysis of PAEE alterations, assessed via wrist-worn accelerometers (acti-watch) Continuous monitoring during intervention period (5-days)
Secondary Sleep duration and quality Analysis of sleep alterations, assessed via wrist-worn device and sleep diary (collectively quantified by analysis of sleep duration, sleep latency, time of sleep onset, no of wakes during night, subjective sleep quality visual analogue scale) Continuous monitoring during intervention period (5-days)
Secondary Changes in Body Composition: Body Mass (kg) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Body Mass Index (kg/m^2) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Fat Mass (kg) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Body Fat Percentage (%) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Fat Free Mass (kg) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Skeletal Muscle Mass (kg) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Total Body Water (l) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Total Body Water (%) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Extra-cellular Water (l) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Extra-cellular Water (%) Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in Body Composition: Extra-cellular Water/Total Body Water ratio Analysis of body composition changes - assessed using bio-electrical impedance analysis (BIA) Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: Ketones Analysis of changes to circulating ketones concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: Glucose Analysis of changes to circulating glucose concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: Free fatty Acids Analysis of changes to circulating free fatty acid concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: Insulin Analysis of changes to circulating insulin concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: Cortisol Analysis of changes to circulating cortisol concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: HDL Analysis of changes to circulating HDL concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: LDL Analysis of changes to circulating LDL concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: glycerol Analysis of changes to circulating glycerol concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: Leptin Analysis of changes to circulating Leptin concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Changes in blood metabolites/hormones: IGF-1 Analysis of changes to circulating IGF-1 concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
Secondary Alterations to skeletal muscle glycogen Assessment of alterations in skeletal muscle glycogen content Days 1 & 5 per intervention (pre-post)
Secondary Alterations to Intra-muscular lipid profile: lipid droplet content Assessment of alterations in lipid droplet content Days 1 & 5 per intervention (pre-post)
Secondary Alterations to Intra-muscular lipid profile: lipid droplet morphology Assessment of alterations in lipid droplet morphology Days 1 & 5 per intervention (pre-post)
Secondary Alterations to Intra-muscular lipid profile: lipid droplet associated proteins Assessment of alterations in lipid droplet associated proteins Days 1 & 5 per intervention (pre-post)
Secondary Resting Metabolic Rate Analysis of changes to Resting Metabolic Rate (kcal/day) following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 3 and 5 of each intervention
Secondary Changes in blood metabolites/hormones: Triiodothyronine (T3) Analysis of changes to circulating T3 concentrations following short term energy balance with a) normal carbohydrate availability and b) low carbohydrate availability Days 1, 2, 3, 4 & 5 per intervention
See also
  Status Clinical Trial Phase
Withdrawn NCT04380155 - Cycling Duration and Bone Markers in in Active Young Adults N/A
Completed NCT04791787 - Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes N/A
Recruiting NCT04910724 - Effects of Varying Energy Deficits on Protein Turnover at Rest and Carbohydrate Oxidation During Steady-state Exercise N/A
Completed NCT04790019 - The Effects of Low Energy Availability and High Impact Jumping on Markers of Bone (re)Modelling in Females N/A
Active, not recruiting NCT05517005 - An Exploratory Investigation of a B12 Vitamin to Increase Energy and Focus N/A
Completed NCT03925168 - Music Therapy and Dialysis: A Pilot Investigation Into the Effectiveness of Patient-Selected Music Interventions on Physiological, Psychological, and Quality-of-Life Outcomes N/A
Completed NCT03052491 - Effects of a 10 Component Dietary Supplement on Health and the Quality of Life N/A
Active, not recruiting NCT05977569 - Physiological and Sensory Responses to Prolonged Fasting in Humans N/A
Completed NCT03222596 - The Impact of Exercise Training on Living Quality in Multiple Sclerosis Individuals N/A
Completed NCT04254900 - Energy Availability in Male and Female Elite Wheelchair Athletes Over Seven Consecutive Training Days
Recruiting NCT06394401 - Optimized Carbohydrate Fueling to Enhance Physical Performance During Energy Deficit N/A
Recruiting NCT03357848 - Impact of Caloric and Protein Adequacy on Postoperative Clinical Outcomes of Patients Undergoing Major Abdominal Surgery N/A
Completed NCT05203133 - Effects of Acute Energy Deficit and Aerobic Exercise on Muscle Quality N/A
Active, not recruiting NCT03264001 - Effects of Progressive Negative Energy Balance on Glucose Tolerance, Insulin Sensitivity, and Beta-cell Function N/A